Trials / Completed
CompletedNCT03182140
KYleena Satisfaction Study / Observational Study on User Satisfaction With the Levonorgestrel Intrauterine Delivery System Kyleena (LNG-IUS 12) in New Contraceptive Users and After Switching From Another Contraceptive Method
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,134 (actual)
- Sponsor
- Bayer · Industry
- Sex
- Female
- Age
- —
- Healthy volunteers
- Accepted
Summary
The main goal of this non-interventional study (NIS) is to evaluate user satisfaction with Kyleena in a real-life setting and to identify factors which influence user satisfaction, taking into account previously used contraceptive methods and reasons for use of Kyleena.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Kyleena | Kyleena - intrauterine delivery system containing 19.5 mg LNG |
Timeline
- Start date
- 2017-07-06
- Primary completion
- 2019-12-19
- Completion
- 2020-03-31
- First posted
- 2017-06-09
- Last updated
- 2021-03-29
Locations
19 sites across 8 countries: United States, Belgium, Canada, Germany, Mexico, Norway, Spain, Sweden
Source: ClinicalTrials.gov record NCT03182140. Inclusion in this directory is not an endorsement.